Atlas Trials

Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization

Clinical trial NCT00555971 · COMPLETED

Trial details

NCT number
NCT00555971
Sponsor
David Lang
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Aspirin Sensitivity
Start date
2006-05-01
Primary completion
2016-02-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.